Citation 1493

KANOKMEDHAKUL,S: KANOKMEDHAKUL,K: KANARSA,T: BUAYAIRAKSA,M:. (2005). NEW BIOACTIVE CLERODANE DITERPENOIDS FROM THE BARK OF CASEARIA GREWIIFOLIA.. 68(2)

Citation Details

TitleNEW BIOACTIVE CLERODANE DITERPENOIDS FROM THE BARK OF CASEARIA GREWIIFOLIA.
AuthorsKANOKMEDHAKUL,S: KANOKMEDHAKUL,K: KANARSA,T: BUAYAIRAKSA,M:
Year2005
Volume68
Issue2

Summary

Year: 2005

Journal: Unknown

Organisms and Their Experiments (1)

Casearia grewiifolia (FLACOURTIACEAE)

Experiment #Pharmacology TypeWorktypesCompoundResults
1Not specified
VOUCHER SPECIMEN REPORTED FORUV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
CASEARGREWIIN A
None
2
ANTIMALARIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
CASEARGREWIIN A
ACTIVE
3
ANTIMYCOBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
CASEARGREWIIN A
ACTIVE
4
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CASEARGREWIIN A
ACTIVE
5
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CASEARGREWIIN A
ACTIVE
6
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CASEARGREWIIN A
ACTIVE
7Not specified
UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATA
CASEARGREWIIN B
None
8
ANTIMALARIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
CASEARGREWIIN B
ACTIVE
9
ANTIMALARIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
CASEARGREWIIN B
ACTIVE
10
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CASEARGREWIIN B
ACTIVE
11
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CASEARGREWIIN B
ACTIVE
12
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CASEARGREWIIN B
ACTIVE
13Not specified
UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
CASEARGREWIIN C
None
14
ANTIMALARIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
CASEARGREWIIN C
ACTIVE
15
ANTIMYCOBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
CASEARGREWIIN C
WEAK ACTIVITY
16
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CASEARGREWIIN C
ACTIVE
17
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CASEARGREWIIN C
ACTIVE
18
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CASEARGREWIIN C
ACTIVE
19Not specified
UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
CASEARGREWIIN D
None
20
ANTIMALARIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
CASEARGREWIIN D
ACTIVE
21
ANTIMYCOBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
CASEARGREWIIN D
ACTIVE
22
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CASEARGREWIIN D
ACTIVE
23
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CASEARGREWIIN D
ACTIVE
24
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CASEARGREWIIN D
ACTIVE
25Not specified
ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATA
CLERODA-3-13(16)-14-TRIENE,18(S)-19(R)-DIACETOXY-18-19-EPOXY-16-METHOXY-2-(2-METHYL-BUTANOYL-OXY): REL: 2(S)-5(R)-6(R)-9(S)-10(R):
None
26
ANTIMALARIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
CLERODA-3-13(16)-14-TRIENE,18(S)-19(R)-DIACETOXY-18-19-EPOXY-16-METHOXY-2-(2-METHYL-BUTANOYL-OXY): REL: 2(S)-5(R)-6(R)-9(S)-10(R):
ACTIVE
27
ANTIMYCOBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
CLERODA-3-13(16)-14-TRIENE,18(S)-19(R)-DIACETOXY-18-19-EPOXY-16-METHOXY-2-(2-METHYL-BUTANOYL-OXY): REL: 2(S)-5(R)-6(R)-9(S)-10(R):
ACTIVE
28
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CLERODA-3-13(16)-14-TRIENE,18(S)-19(R)-DIACETOXY-18-19-EPOXY-16-METHOXY-2-(2-METHYL-BUTANOYL-OXY): REL: 2(S)-5(R)-6(R)-9(S)-10(R):
ACTIVE
29
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CLERODA-3-13(16)-14-TRIENE,18(S)-19(R)-DIACETOXY-18-19-EPOXY-16-METHOXY-2-(2-METHYL-BUTANOYL-OXY): REL: 2(S)-5(R)-6(R)-9(S)-10(R):
ACTIVE
30
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CLERODA-3-13(16)-14-TRIENE,18(S)-19(R)-DIACETOXY-18-19-EPOXY-16-METHOXY-2-(2-METHYL-BUTANOYL-OXY): REL: 2(S)-5(R)-6(R)-9(S)-10(R):
ACTIVE
31Not specified
ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATA
CLERODA-1-13(16)-14-TRIENE,18(S)-19(R)-DIACETOXY-18-19-EPOXY-6-HYDROXY-2-(2-METHYL-BUTANOYL-OXY):
None
32
ANTIMALARIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
CLERODA-1-13(16)-14-TRIENE,18(S)-19(R)-DIACETOXY-18-19-EPOXY-6-HYDROXY-2-(2-METHYL-BUTANOYL-OXY):
ACTIVE
33
ANTIMYCOBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
CLERODA-1-13(16)-14-TRIENE,18(S)-19(R)-DIACETOXY-18-19-EPOXY-6-HYDROXY-2-(2-METHYL-BUTANOYL-OXY):
ACTIVE
34
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CLERODA-1-13(16)-14-TRIENE,18(S)-19(R)-DIACETOXY-18-19-EPOXY-6-HYDROXY-2-(2-METHYL-BUTANOYL-OXY):
ACTIVE
35
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CLERODA-1-13(16)-14-TRIENE,18(S)-19(R)-DIACETOXY-18-19-EPOXY-6-HYDROXY-2-(2-METHYL-BUTANOYL-OXY):
ACTIVE
36
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CLERODA-1-13(16)-14-TRIENE,18(S)-19(R)-DIACETOXY-18-19-EPOXY-6-HYDROXY-2-(2-METHYL-BUTANOYL-OXY):
ACTIVE
Show SPARQL Queries (1)